Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | UCHL1 | P09936 | 9/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | USP30 | Q70CQ3 | 8/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TYK2 | P29597 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8627107 | 0.78 | MEN1 (0.47) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL77860 | 0.77 | UCHL1 (0.60) | MAPTMEN1KMT2ACPB1UCHL1 | |
| SCHEMBL13662109 | 0.71 | MEN1 (0.56) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL15689336 | 0.71 | NPC1 (0.70) | MAPTMEN1KMT2ACPB1UCHL1 | |
| SCHEMBL91379 | 0.70 | RAB9A (0.56) | MEN1KMT2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9834154 | 0.70 | LMNA (0.50) | MAPTMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL17107203 | 0.69 | UCHL1 (0.63) | MAPTMEN1KMT2ACPB1UCHL1 | |
| SCHEMBL17107125 | 0.68 | UCHL1 (0.62) | MAPTMEN1KMT2ACPB1UCHL1 | |
| SCHEMBL15688988 | 0.67 | RAB9A (0.67) | MAPTMEN1KMT2ACPB1UCHL1 | |
| SCHEMBL18674680 | 0.67 | MEN1 (0.41) | MEN1KMT2ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129415-B2 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | HAAO, HAO1, CYP51A1 | MAPT 2769/4885MEN1 930/4885KMT2A 609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.